Education
About Us
Working with TipRanks
Follow Us
Prime Medicine, Inc. (PRME)
NASDAQ:PRME
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 2.98M | $ 0.00 | $ 0.00 | $ 0.00 | $ 5.21M |
| Gross Profit | $ 2.98M | $ 0.00 | $ 0.00 | $ 0.00 | $ 2.23M |
| Operating Income | $ -202.47M | $ -204.79M | $ -116.54M | $ -84.47M | $ -932.00K |
| EBITDA | $ -196.34M | $ -186.64M | $ -114.32M | $ -83.91M | $ -889.00K |
| Net Income | $ -195.88M | $ -198.13M | $ -121.82M | $ -165.37M | $ -3.41M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 190.44M | $ 121.67M | $ 293.92M | $ 269.62M | $ 53.33M |
| Total Assets | $ 297.51M | $ 193.85M | $ 360.31M | $ 301.86M | $ 54.78M |
| Total Debt | $ 40.79M | $ 13.63M | $ 28.75M | $ 10.41M | $ 0.00 |
| Net Debt | $ -141.68M | $ -27.94M | $ -158.88M | $ -175.01M | $ -36.98M |
| Total Liabilities | $ 144.36M | $ 60.78M | $ 44.04M | $ 62.30M | $ 21.31M |
| Stockholders' Equity | $ 153.15M | $ 133.07M | $ 316.27M | $ 239.56M | $ 33.47M |
| Cash Flow | |||||
| Free Cash Flow | $ -130.16M | $ -174.14M | $ -147.92M | $ -38.23M | $ -6.18M |
| Operating Cash Flow | $ -122.86M | $ -165.41M | $ -131.83M | $ -34.08M | $ -5.54M |
| Investing Cash Flow | $ 68.46M | $ 18.71M | $ -47.10M | $ -73.63M | $ -1.06M |
| Financing Cash Flow | $ 195.88M | $ 655.00K | $ 181.49M | $ 269.28M | $ 34.93M |
Prime Medicine, Inc. Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.